Filter Results :

Your search for Immune returned 150 reports

Sort by


TapImmune Inc. (TPIV) - Financial and Strategic SWOT Analysis Review

09 Jan 2015  |  Published by:  GlobalData
SummaryTapImmune Inc. (TapImmune) is a biotechnology company. The company develops peptide and gene-based immunotherapeutics and vaccines for the treatment of oncology and infectious disease. Its immunotherapy technologies are used to prevent emerging viral pathogens for pandemics and biodefense. Ta...

$ 300.00

Read More

Adimmune Corporation (4142) - Financial and Strategic SWOT Analysis Review

09 Jan 2015  |  Published by:  GlobalData
SummaryAdimmune Corporation (Adimmune) is a pharmaceutical company. The company manufactures products, such as vaccines, diagnostics, and biological products. The company’s vaccine products include Japan encephalitis vaccine, tetanus toxoid adsorbed vaccine, influenza vaccine, and ah1n1 vaccine. It ...

$ 300.00

Read More

Primary Immune Deficiency (PID) - Pipeline Review, H2 2014

31 Dec 2014  |  Published by:  Global Markets Direct
Summary ‘Primary Immune Deficiency (PID) - Pipeline Review, H2 2014’, provides an overview of the Primary Immune Deficiency (PID)’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Primary Immune Deficiency (PID), complete with comparative analys...

$ 2,000.00

Read More

Immune Design Corp. - Product Pipeline Review - 2014

10 Dec 2014  |  Published by:  Global Markets Direct
Summary'Immune Design Corp. - Product Pipeline Review - 2014’, provides an overview of the Immune Design Corp.’s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Immune Design Corp.’s, complete with comp...

$ 1,500.00

Read More

Autoimmune Drugs Markets in China

01 Dec 2014  |  Published by:  Asia Market Info and Dev Co.
China's demand for Autoimmune Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & exp...

$ 4,000.00

Read More

Immune Response BioPharma, Inc. - Product Pipeline Review - 2014

24 Nov 2014  |  Published by:  Global Markets Direct
Summary‘Immune Response BioPharma, Inc. - Product Pipeline Review - 2014’, provides an overview of the Immune Response BioPharma, Inc.’s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Immune Response B...

$ 1,500.00

Read More

SYNIMMUNE GmbH - Product Pipeline Review - 2014

24 Nov 2014  |  Published by:  Global Markets Direct
Summary‘SYNIMMUNE GmbH - Product Pipeline Review - 2014’, provides an overview of the SYNIMMUNE GmbH’s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of SYNIMMUNE GmbH’s, complete with comparative analysi...

$ 1,500.00

Read More

Immune-tree International, Inc. - Strategic SWOT Analysis Review

21 Nov 2014  |  Published by:  GlobalData
SummaryImmune-tree International, Inc. (Immune tree) is a healthcare product company. The company develops and manufactures colostrum and colostrum based products. Immune tree’s products include colostrum capsules, colostrum 2.5oz powder, colostrum 6.5oz powder, colostrum kilo powder, colostrum pine...

$ 300.00

Read More

TapImmune Inc. (TPIV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

21 Nov 2014  |  Published by:  GlobalData
SummaryTapImmune Inc. (TapImmune) is a biotechnology company. The company develops peptide and gene-based immunotherapeutics and vaccines for the treatment of oncology and infectious disease. Its immunotherapy technologies are used to prevent emerging viral pathogens for pandemics and biodefense. Ta...

$ 250.00

Read More

Immune Network, Ltd. - Strategic SWOT Analysis Review

21 Nov 2014  |  Published by:  GlobalData
SummaryImmune Network, Ltd. (INR) is a healthcare company. The company discovers and develops drugs for the treatment of various immunological diseases in Canada. It offers pre-clinical and clinical immunotherapeutics and immunitor products. The company provides vaccines against microbial and fungal...

$ 300.00

Read More

Omnimmune Holdings, Inc. (OMMH) - Financial and Strategic SWOT Analysis Review

21 Nov 2014  |  Published by:  GlobalData
SummaryOmnimmune Holdings, Inc. (Omnimmune) is a development-stage biotechnology company, engaged in providing diagnostic, prognostic and therapeutic interventions in the clinical management of cancer. Omnimmune acquired the licensed rights to breakthrough platform monoclonal antibody technologies a...

$ 300.00

Read More

REGiMMUNE Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

19 Nov 2014  |  Published by:  GlobalData
SummaryREGiMMUNE Corporation (REGiMMUNE) is a biotechnology company. The company develops therapies for immune diseases and disorders using immune-regulating technology. Its pipeline products include RGI-2001 (GvHD), RGI-3100 (TID), RGI-5000s (ERT), and RGI-1001 (cedar allergy). The company speciali...

$ 250.00

Read More

Immune Pharmaceuticals, Inc. (IMNP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

19 Nov 2014  |  Published by:  GlobalData
SummaryImmune Pharmaceuticals, Ltd. (Immune Pharmaceuticals) is a biopharmaceutical company. The company develops and markets monoclonal antibodies for the treatment of inflammatory diseases and cancer. Its product pipeline includes bertilimumab, nanomabs, amiket, and crolibulin. Immune Pharmaceutic...

$ 250.00

Read More

CytImmune Sciences, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

19 Nov 2014  |  Published by:  GlobalData
SummaryCytImmune Sciences, Inc. (CytImmune Sciences) is a nanomedicine company. The company discovers, develops, and commercializes tumor-targeted therapies for the treatment of cancer. Its product portfolio includes Aurimune, Auritol and human monoclonal antibody therapeutics. The company develops ...

$ 250.00

Read More

Immune Targeting Systems (ITS) Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

19 Nov 2014  |  Published by:  GlobalData
SummaryImmune Targeting Systems (ITS) Ltd. (Immune Targeting) is a life science company. The company develops synthetic vaccines for mutating viruses. Its lead product is a synthetic pan-strain influenza A vaccine targeting all potential seasonal and pandemic flu strains and is currently in phase-I ...

$ 250.00

Read More
Total 150 records.